Patricia L. Allen's most recent trade in Zenas Biopharma Inc. was a trade of 18,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zenas Biopharma Inc | Patricia L. Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2026 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| Zenas Biopharma Inc | Patricia L. Allen | Director | Purchase of securities on an exchange or from another person at price $ 24.34 per share. | 12 Feb 2026 | 5,700 | 10,700 | - | 24.3 | 138,738 | Common Stock |
| Zenas Biopharma Inc | Patricia L. Allen | Director | Purchase of securities on an exchange or from another person at price $ 23.77 per share. | 12 Feb 2026 | 5,000 | 5,000 | - | 23.8 | 118,850 | Common Stock |
| Zenas Biopharma Inc | Patricia L. Allen | Director | Purchase of securities on an exchange or from another person at price $ 26.50 per share. | 12 Feb 2026 | 5,000 | 15,700 | - | 26.5 | 132,500 | Common Stock |
| Zenas Biopharma Inc | Patricia L. Allen | Director | Purchase of securities on an exchange or from another person at price $ 26.36 per share. | 12 Feb 2026 | 4,160 | 19,860 | - | 26.4 | 109,658 | Common Stock |
| Zenas Biopharma Inc | Patricia L. Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| Zenas Biopharma Inc | Patricia L. Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | Patricia L. Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 4,727 | 4,727 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | Patricia L. Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | Patricia L. Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 3,269 | 3,269 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | Patricia L. Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | Patricia L. Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 9,570 | 9,570 | - | - | Stock Option (Right to Buy) |